Hydrocortisone Use in Severe Community‑Acquired Pneumonia: Evidence‑Based Recommendations

Dosing and Duration

Administer hydrocortisone at a total daily dose ≤ 400 mg (e.g., 200 mg/day) for 5–7 days, followed by tapering to complete a total course of 8–14 days; higher doses have not demonstrated additional benefit and may increase adverse effects. (Critical Care Medicine, 2018) 1

Severe CAP definition (Clinical Infectious Diseases, 2007) requires either one major criterion (invasive mechanical ventilation or septic shock needing vasopressors) or at least three minor criteria (e.g., respiratory rate ≥ 30 breaths/min, PaO₂/FiO₂ < 250, multilobar infiltrates, altered mental status, BUN ≥ 20 mg/dL, leukopenia, thrombocytopenia, hypothermia, or need for aggressive fluid resuscitation). (Clinical Infectious Diseases, 2007) [2][3]

The Society of Critical Care Medicine / European Society of Intensive Care Medicine (2018) issues a conditional recommendation (moderate‑quality evidence) to use low‑dose corticosteroids (< 400 mg/day hydrocortisone equivalent) for 5–7 days in hospitalized patients with severe CAP. (Critical Care Medicine, 2018) 1

Corticosteroids should not be used in influenza‑related pneumonia. Observational data associate steroid use with a three‑fold increase in mortality (OR ≈ 3.0) and higher rates of secondary bacterial infection. The American Thoracic Society explicitly advises against steroids in this setting. (Critical Care Medicine, 2018) 1

Hyperglycemia is the most common adverse effect, occurring in roughly 50 % more patients receiving hydrocortisone (RR ≈ 1.7). Close glucose monitoring, especially during the first 36 hours, and readiness to adjust insulin therapy are required. (Critical Care Medicine, 2018) 1
No statistically significant increase in secondary infections (RR ≈ 1.0) or gastrointestinal bleeding (RR ≈ 1.07) has been observed with low‑dose hydrocortisone. (Critical Care Medicine, 2018) 1

Early low‑dose hydrocortisone reduces the risk of acute respiratory distress syndrome (ARDS) (RR ≈ 0.24). (Critical Care Medicine, 2018) 1
In patients with septic shock, hydrocortisone improves shock reversal rates (RR ≈ 1.20). (Critical Care Medicine, 2018) 1

The American College of Physicians recommends hydrocortisone less than 400 mg/day (typically 200 mg/day) for 5-7 days as an alternative regimen for severe CAP, particularly in patients with septic shock 4, 5
The guideline suggests that hydrocortisone should be given as continuous infusion or divided doses rather than bolus administration 4

Corticosteroids are indicated for CAP with septic shock, particularly when hemodynamic stability cannot be restored with adequate fluid resuscitation and vasopressor therapy 4, 5
The American Thoracic Society recommends against using corticosteroids in patients with influenza pneumonia, as observational data shows increased mortality and risk of secondary bacterial infections 6

The American Diabetes Association notes that dexamethasone treatment requires glucose monitoring and management during treatment due to the increased risk of hyperglycemia 5
The American Journal of Respiratory and Critical Care Medicine recommends monitoring patients closely after discharge due to the trend toward higher readmission rates 7

The Infectious Diseases Society of America recommends always providing antibacterial coverage alongside corticosteroids according to standard CAP guidelines, as corticosteroids are adjunctive therapy only 7, 5